Becky
01-15-2011, 10:09 AM
Dear Members:
In conjunction with our ongoing relationship with Genentech, Her2Support has been asked to participate in a survey for Her2+ metastatic patients. Please participate if you are comfortable to do so. It is completely private. Below is a synopsis on the details and the link below to participate in the survey.
----------------------------------------------------------------------------------------------------------------------
In coordination with Genentech (survey sponsor) and Boston Health Economics, Inc. (survey management company), we invite HER2 Support to participate in a survey focused on the experiences of women with HER2+ metastatic breast cancer. The purpose of the survey is to better understand the many different aspects of life with metastatic breast cancer, including treatment and symptom experience, health, and overall well-being. Genentech will donate $10 to HER2 Support for every survey completed via the link below (up to 50 completed surveys). The web-based survey is expected to take approximately 30 minutes to complete. Participants will have the option to stop and return to the survey later if they so choose. As long as they click on the same link to access the survey (given below) and use the same computer as when they started, they will return to where they left off.
We appreciate your assistance in this research effort. Please note, researchers will not be able to link survey responses to individual participants as the survey does not ask for any identifying or contact information. The researchers plan to publish the results of this study, but, again, they will not have any information that would identify specific individuals. Participating in this study is completely voluntary.
http://survey.qualtrics.com/SE/?SID=SV_bgbkFAElJx8xMJm&advocacyGroupId=2
In conjunction with our ongoing relationship with Genentech, Her2Support has been asked to participate in a survey for Her2+ metastatic patients. Please participate if you are comfortable to do so. It is completely private. Below is a synopsis on the details and the link below to participate in the survey.
----------------------------------------------------------------------------------------------------------------------
In coordination with Genentech (survey sponsor) and Boston Health Economics, Inc. (survey management company), we invite HER2 Support to participate in a survey focused on the experiences of women with HER2+ metastatic breast cancer. The purpose of the survey is to better understand the many different aspects of life with metastatic breast cancer, including treatment and symptom experience, health, and overall well-being. Genentech will donate $10 to HER2 Support for every survey completed via the link below (up to 50 completed surveys). The web-based survey is expected to take approximately 30 minutes to complete. Participants will have the option to stop and return to the survey later if they so choose. As long as they click on the same link to access the survey (given below) and use the same computer as when they started, they will return to where they left off.
We appreciate your assistance in this research effort. Please note, researchers will not be able to link survey responses to individual participants as the survey does not ask for any identifying or contact information. The researchers plan to publish the results of this study, but, again, they will not have any information that would identify specific individuals. Participating in this study is completely voluntary.
http://survey.qualtrics.com/SE/?SID=SV_bgbkFAElJx8xMJm&advocacyGroupId=2